TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Number of Point-of-Care (POC) Diagnostics procedures by key countries, 2018 4.2. Price analysis of types of Point-of-Care (POC) Diagnostics 4.3. Regulatory scenario by key countries 4.4. Reimbursement scenario by key countries 4.5. New product launches 4.6. Key industry developments - mergers, acquisitions, and partnerships 4.7. Key growth indicators of Point-of-Care (POC) Diagnostics market 5. Global Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Product 5.2.1. Blood Glucose Monitoring 5.2.2. Infectious Diseases 5.2.3. Cardiometabolic Diseases 5.2.4. Pregnancy and Fertility Testing Products 5.2.5. Hematology Testing Products 5.2.6. Others 5.3. Market Analysis, Insights and Forecast – By End User 5.3.1. Hospitals Bedside 5.3.2. Physician’s Office Lab 5.3.3. Urgent Care & Retail Clinics 5.3.4. Home and Self Testing 5.4. Market Analysis, Insights and Forecast – By Region 5.4.1. North America 5.4.2. Europe 5.4.3. Asia pacific 5.4.4. Latin America 5.4.5. Middle East & Africa 6. North America Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Product 6.2.1. Blood Glucose Monitoring 6.2.2. Infectious Diseases 6.2.3. Cardiometabolic Diseases 6.2.4. Pregnancy and Fertility Testing Products 6.2.5. Hematology Testing Products 6.2.6. Others 6.3. Market Analysis – By End User 6.3.1. Hospitals Bedside 6.3.2. Physician’s Office Lab 6.3.3. Urgent Care & Retail Clinics 6.3.4. Home and Self Testing 6.4. Market Analysis – By Country 6.4.1. U.S. 6.4.2. Canada 7. Europe Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis – By Product 7.2.1. Blood Glucose Monitoring 7.2.2. Infectious Diseases 7.2.3. Cardiometabolic Diseases 7.2.4. Pregnancy and Fertility Testing Products 7.2.5. Hematology Testing Products 7.2.6. Others 7.3. Market Analysis – By End User 7.3.1. Hospitals Bedside 7.3.2. Physician’s Office Lab 7.3.3. Urgent Care & Retail Clinics 7.3.4. Home and Self Testing 7.4. Market Analysis – By Country/Sub-region 7.4.1. U.K. 7.4.2. Germany 7.4.3. France 7.4.4. Spain 7.4.5. Italy 7.4.6. Scandinavia 7.4.7. Rest of Europe 8. Asia pacific Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis – By Product 8.2.1. Blood Glucose Monitoring 8.2.2. Infectious Diseases 8.2.3. Cardiometabolic Diseases 8.2.4. Pregnancy and Fertility Testing Products 8.2.5. Hematology Testing Products 8.2.6. Others 8.3. Market Analysis – By End User 8.3.1. Hospitals Bedside 8.3.2. Physician’s Office Lab 8.3.3. Urgent Care & Retail Clinics 8.3.4. Home and Self Testing 8.4. Market Analysis – By Country/Sub-region 8.4.1. Japan 8.4.2. China 8.4.3. India 8.4.4. Australia 8.4.5. Southeast Asia 8.4.6. Rest of Asia Pacific 9. Latin America Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis – By Product 9.2.1. Blood Glucose Monitoring 9.2.2. Infectious Diseases 9.2.3. Cardiometabolic Diseases 9.2.4. Pregnancy and Fertility Testing Products 9.2.5. Hematology Testing Products 9.2.6. Others 9.3. Market Analysis – By End User 9.3.1. Hospitals Bedside 9.3.2. Physician’s Office Lab 9.3.3. Urgent Care & Retail Clinics 9.3.4. Home and Self Testing 9.4. Market Analysis – By Country/Sub-region 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 10. Middle East & Africa Point-of-Care (POC) Diagnostics Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis – By Product 10.2.1. Blood Glucose Monitoring 10.2.2. Infectious Diseases 10.2.3. Cardiometabolic Diseases 10.2.4. Pregnancy and Fertility Testing Products 10.2.5. Hematology Testing Products 10.2.6. Others 10.3. Market Analysis – By End User 10.3.1. Hospitals Bedside 10.3.2. Physician’s Office Lab 10.3.3. Urgent Care & Retail Clinics 10.3.4. Home and Self Testing 10.4. Market Analysis – By Country/Sub-region 10.4.1. GCC Countries 10.4.2. South Africa 10.4.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1. Abbott 11.5.2. Johnson & Johnson Services, Inc. 11.5.3. Becton, Dickinson and Company (BD) 11.5.4. Quidel Corporation 11.5.5. Sekisui Diagnostics 11.5.6. Danaher 11.5.7. Siemens Healthcare GmbH 11.5.8. AccuBioTech Co., Ltd. 11.5.9. Chembio Diagnostic Systems, Inc. 11.5.10. EKF Diagnostics Holdings plc 11.5.11. Instrumentation Laboratory (A Werfen Company) 11.5.12. Nova Biomedical 11.5.13. PTS Diagnostics

Abbott Johnson & Johnson Services, Inc. Becton, Dickinson and Company (BD) Quidel Corporation Sekisui Diagnostics Danaher Siemens Healthcare GmbH AccuBioTech Co., Ltd. Chembio Diagnostic Systems, Inc. EKF Diagnostics Holdings plc Instrumentation Laboratory (A Werfen Company) Nova Biomedical PTS Diagnostics